Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ·Healthcare·Biotechnology
$15.81
-0.72%
Mkt Cap $1.35B
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (12 analysts)
$31.80
Range $27.00 – $42.00
Implied Upside
+101.2%
Consensus $31.80 vs current $15.81
NASDAQ·Healthcare·Biotechnology
$15.81
-0.72%
Mkt Cap $1.35B
Buy
5
Hold
0
Sell
0
Price Target (12 analysts)
$31.80
Range $27.00 – $42.00
+101.2%
Consensus $31.80 vs current $15.81